跳至主要内容
临床试验/NCT02501993
NCT02501993进行中(未招募)不适用

Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City

Zhongshan People's Hospital, Guangdong, China1 个研究点 分布在 1 个国家目标入组 25,000 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
25,000
试验地点
1
主要终点
The early detection rate (stage I and II) of Nasopharyngeal Carcinoma

研究概览

简要总结

The primary objective is to determine the early diagnosis rate and mortality rate of the Nasopharyngeal Carcinoma (NPC) in the study population.

The secondary objective is to determine the incidence of NPC in the study population.

详细描述

The research is to evaluate the effect of NPC screening, also as an extended study of Screening for Nasopharyngeal Carcinoma in High Risk Populations (NCT00941538).

The program was conducted in Xiaolan and Minzhong towns of Zhongshan city in 2012.

All participants will be tested for anti-EBV antibody by using serum samples. Participants are stratified into those having high, moderate and low antibody levels, those having moderate antibody levels are invited to retest annually in the following 3 years and those found to have high antibody levels on these occasions are referred to centers for diagnostic workup for NPC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subject residents in Zhongshan city
  • Subject is 30 to 59 years of age inclusive
  • Subject has no medical record of nasopharyngeal carcinoma
  • Subject has psychical condition and well consciousness
  • Subject is able to comprehend, sign, and date the written informed consent document to participate in the study.

排除标准

  • Subject has heavy cardiovascular, liver or kidney disease
  • Subject has medical record of nasopharyngeal carcinoma
  • Subject who is not residing in Zhongshan City

结局指标

主要结局

The early detection rate (stage I and II) of Nasopharyngeal Carcinoma

时间窗: 10 years

The mortality rate of Nasopharyngeal Carcinoma

时间窗: 10 years

次要结局

  • The incidence of Nasopharyngeal Carcinoma(10 years)

研究者

发起方
Zhongshan People's Hospital, Guangdong, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mingfang Ji

Principal Investigator

Zhongshan People's Hospital, Guangdong, China

研究点 (1)

Loading locations...

相似试验